New Delhi, Jan 20 (PTI) Strides Pharma Science Ltd on Monday said its wholly-owned arm Strides Pharma Global Pte. Limited, Singapore, has received approval from the US health regulator for its generic pain-relieving Acetaminophen and Ibuprofen tablets.

The approval by the US Food & Drug Administration (USFDA) is for generic over-the-counter (OTC) Acetaminophen and Ibuprofen tablets of strength 125 mg /250 mg, Strides Pharma Science said in a statement.

Also Read | 8th Pay Commission for Pensioners: What Will Be Minimum Pension if Fitment Factor Raised to 2.86? Check Details Here.

The product is bioequivalent to the reference listed drug (RLD), Advil Dual Action with Acetaminophen, 125 mg /250 mg (OTC), of Haleon US Holdings LLC, it added.

"The addition of the Acetaminophen and Ibuprofen tablets, 125 mg /250 mg (OTC) will significantly enhance our existing portfolio of OTC products. By offering a dual-action pain relief option, we aim to cater to a broader patient base, providing effective and accessible solutions for pain management," the company said.

Also Read | How To Buy Trump Coin, Melania Coin? Check Step-by-Step Guide To Get $TRUMP and $MELANIA Cryptocurrency Tokens on Different Crypto Exchange.

Acetaminophen and Ibuprofen tablets will be manufactured at the company's flagship facility in KRSG, Bengaluru, it added.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)